拓扑异构酶IIα控制解连环检查点。
Topoisomerase IIalpha controls the decatenation checkpoint.
作者信息
Luo Kuntian, Yuan Jian, Chen Junjie, Lou Zhenkun
机构信息
Division of Oncology Research, Department of Oncology, Mayo Clinic, Rochester, MN 55905, USA.
出版信息
Nat Cell Biol. 2009 Feb;11(2):204-10. doi: 10.1038/ncb1828. Epub 2008 Dec 21.
Abstract
Topoisomerase II (Topo II) is required to separate intertwined sister chromatids before chromosome segregation can occur in mitosis. However, it remains to be resolved whether Topo II has any role in checkpoint control. Here we report that when phosphorylated, Ser 1524 of Topo IIalpha acts as a binding site for the BRCT domain of MDC1 (mediator of DNA damage checkpoint protein-1), thereby recruiting MDC1 to chromatin. Although Topo IIalpha-MDC1 interaction is not required for checkpoint activation induced by DNA damage, it is required for activation of the decatenation checkpoint. Mutation of Ser 1524 results in a defective decatenation checkpoint. These results reveal an important role of Topo II in checkpoint activation and in the maintenance of genomic stability.
摘要
在有丝分裂中，染色体分离发生之前，拓扑异构酶II（Topo II）是解开相互缠绕的姐妹染色单体所必需的。然而，Topo II在检查点控制中是否发挥作用仍有待解决。在此我们报告，当Topo IIα的丝氨酸1524被磷酸化时，它作为MDC1（DNA损伤检查点蛋白-1的介质）的BRCT结构域的结合位点，从而将MDC1招募到染色质上。虽然DNA损伤诱导的检查点激活不需要Topo IIα-MDC1相互作用，但它是解连环检查点激活所必需的。丝氨酸1524的突变导致解连环检查点缺陷。这些结果揭示了Topo II在检查点激活和维持基因组稳定性中的重要作用。
相似文献
1
Topoisomerase IIalpha controls the decatenation checkpoint.
Nat Cell Biol. 2009 Feb;11(2):204-10. doi: 10.1038/ncb1828. Epub 2008 Dec 21.
2
Roles of the C-terminal domains of topoisomerase IIα and topoisomerase IIβ in regulation of the decatenation checkpoint.
Nucleic Acids Res. 2017 Jun 2;45(10):5995-6010. doi: 10.1093/nar/gkx325.
3
NFBD1/MDC1 is phosphorylated by PLK1 and controls G2/M transition through the regulation of a TOPOIIα-mediated decatenation checkpoint.
PLoS One. 2013 Dec 11;8(12):e82744. doi: 10.1371/journal.pone.0082744. eCollection 2013.
4
Topoisomerase IIalpha maintains genomic stability through decatenation G(2) checkpoint signaling.
Oncogene. 2010 Aug 26;29(34):4787-99. doi: 10.1038/onc.2010.232. Epub 2010 Jun 21.
5
A novel chromatin tether domain controls topoisomerase IIα dynamics and mitotic chromosome formation.
J Cell Biol. 2013 Nov 11;203(3):471-86. doi: 10.1083/jcb.201303045.
6
Geminin overexpression prevents the completion of topoisomerase IIα chromosome decatenation, leading to aneuploidy in human mammary epithelial cells.
Breast Cancer Res. 2011 May 19;13(3):R53. doi: 10.1186/bcr2884.
7
Fbxo28 promotes mitotic progression and regulates topoisomerase IIα-dependent DNA decatenation.
Cell Cycle. 2016 Dec 16;15(24):3419-3431. doi: 10.1080/15384101.2016.1246093. Epub 2016 Oct 18.
8
Casein kinase I delta/epsilon phosphorylates topoisomerase IIalpha at serine-1106 and modulates DNA cleavage activity.
Nucleic Acids Res. 2009 Feb;37(2):382-92. doi: 10.1093/nar/gkn934. Epub 2008 Nov 29.
9
DNA-binding activity of rat DNA topoisomerase II α C-terminal domain contributes to efficient DNA catenation in vitro.
J Biochem. 2016 Mar;159(3):363-9. doi: 10.1093/jb/mvv110. Epub 2015 Nov 1.
10
Metnase mediates chromosome decatenation in acute leukemia cells.
Blood. 2009 Aug 27;114(9):1852-8. doi: 10.1182/blood-2008-08-175760. Epub 2009 May 20.
引用本文的文献
1
Yeast Tools for Studying Type II Topoisomerases in Budding Yeast.
Methods Mol Biol. 2025;2928:123-150. doi: 10.1007/978-1-0716-4550-5_12.
2
Mutagenesis of Intrinsically Disordered Domain Impacts Topoisomerase IIα Catalytic Activity.
Int J Mol Sci. 2025 Apr 11;26(8):3604. doi: 10.3390/ijms26083604.
3
DeSUMOylating isopeptidase 1 participates in the faithful chromosome segregation and vincristine sensitivity.
FASEB J. 2024 Dec 13;38(24):e70261. doi: 10.1096/fj.202401560RR.
4
Advances in research on malignant tumors and targeted agents for TOP2A (Review).
Mol Med Rep. 2025 Feb;31(2). doi: 10.3892/mmr.2024.13415. Epub 2024 Dec 13.
5
Bioinformatic Analysis of Topoisomerase IIα Reveals Interdomain Interdependencies and Critical C-Terminal Domain Residues.
Int J Mol Sci. 2024 May 23;25(11):5674. doi: 10.3390/ijms25115674.
6
Mitotic chromosomes are self-entangled and disentangle through a topoisomerase-II-dependent two-stage exit from mitosis.
Mol Cell. 2024 Apr 18;84(8):1422-1441.e14. doi: 10.1016/j.molcel.2024.02.025. Epub 2024 Mar 22.
7
The Role of the AT-Rich Interaction Domain 1A Gene () in Human Carcinogenesis.
Genes (Basel). 2023 Dec 19;15(1):5. doi: 10.3390/genes15010005.
8
Cell cycle responses to Topoisomerase II inhibition: Molecular mechanisms and clinical implications.
J Cell Biol. 2023 Dec 4;222(12). doi: 10.1083/jcb.202209125. Epub 2023 Nov 13.
9
In silico study reveals unconventional interactions between MDC1 of DDR and Beclin-1 of autophagy.
Mol Divers. 2023 Dec;27(6):2789-2802. doi: 10.1007/s11030-022-10579-2. Epub 2022 Dec 8.
10
Regulation of the mitotic chromosome folding machines.
Biochem J. 2022 Oct 28;479(20):2153-2173. doi: 10.1042/BCJ20210140.
本文引用的文献
1
Polo on the Rise-from Mitotic Entry to Cytokinesis with Plk1.
Dev Cell. 2008 May;14(5):646-59. doi: 10.1016/j.devcel.2008.04.014.
2
A mitotic topoisomerase II checkpoint in budding yeast is required for genome stability but acts independently of Pds1/securin.
Genes Dev. 2006 May 1;20(9):1162-74. doi: 10.1101/gad.1367206.
3
Cell cycle-dependent DNA damage signaling induced by ICRF-193 involves ATM, ATR, CHK2, and BRCA1.
Exp Cell Res. 2006 Jul 1;312(11):1996-2008. doi: 10.1016/j.yexcr.2006.02.029. Epub 2006 Apr 21.
4
gammaH2AX and MDC1: anchoring the DNA-damage-response machinery to broken chromosomes.
DNA Repair (Amst). 2006 May 10;5(5):534-43. doi: 10.1016/j.dnarep.2006.01.012. Epub 2006 Mar 10.
5
Decatenation checkpoint deficiency in stem and progenitor cells.
Cancer Cell. 2005 Dec;8(6):479-84. doi: 10.1016/j.ccr.2005.11.004.
6
Methylation of histone H4 lysine 20 controls recruitment of Crb2 to sites of DNA damage.
Cell. 2004 Nov 24;119(5):603-14. doi: 10.1016/j.cell.2004.11.009.
7
Methylated lysine 79 of histone H3 targets 53BP1 to DNA double-strand breaks.
Nature. 2004 Nov 18;432(7015):406-11. doi: 10.1038/nature03114. Epub 2004 Nov 3.
8
Identification of decatenation G2 checkpoint impairment independently of DNA damage G2 checkpoint in human lung cancer cell lines.
Cancer Res. 2004 Jul 15;64(14):4826-32. doi: 10.1158/0008-5472.CAN-04-0871.
9
Cell cycle checkpoint function in bladder cancer.
J Natl Cancer Inst. 2003 Dec 17;95(24):1859-68. doi: 10.1093/jnci/djg120.
10
Phosphopeptide binding specificities of BRCA1 COOH-terminal (BRCT) domains.
J Biol Chem. 2003 Dec 26;278(52):52914-8. doi: 10.1074/jbc.C300407200. Epub 2003 Oct 24.
Zotero 插件